Kelly Youngblood
Known title: See RemarksCIK: 0001673745
Associated companies
Transaction History
| CTRI | ▲ Buy | Grant | 72,864 | $0 | 8/12/2026 | View on chart |
| CTRI | ▲ Buy | Grant | 72,864 | $0 | 8/12/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Baird Highlights Centuri Holdings Growth Potential Amid Options Activity
Baird recently noted strong growth potential for Centuri Holdings, while other reports discussed options market activity and the company's path to profitability. The stock currently trades near its average analyst target of $28.50, with a wide target range reflecting varying views on its valuation. These developments suggest ongoing debate about the company's future earnings trajectory.
Baird Highlights Centuri Holdings Growth Potential Amid Options Activity. Baird recently noted strong growth potential for Centuri Holdings, while other reports discussed options market activity and the company's path to profitability. The stock currently trades near its average analyst target of $28.50, with a wide target range reflecting varying views on its valuation. These developments suggest ongoing debate about the company's future earnings trajectory.